Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Keiko Mitamura
Trivalent Inactivated Influenza Vaccine Effective Against Influenza A(H3N2) Variant Viruses in Children During the 2014/15 Season, Japan
Eurosurveillance
Environmental
Virology
Public Health
Epidemiology
Medicine
Occupational Health
Clinical Evaluation of the Immunochromatographic System Using Silver Amplification for the Rapid Detection of Mycoplasma Pneumoniae
Scientific Reports
Multidisciplinary
Related publications
Efficacy of Trivalent, Cold-Adapted, Influenza Virus Vaccine Against Influenza a (Fujian), a Drift Variant, During 2003–2004
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine
Pediatric Research
Child Health
Pediatrics
Perinatology
Trivalent Inactivated Influenza Vaccine Is Not Associated With Sickle Cell Crises in Children
Pediatrics
Child Health
Pediatrics
Perinatology
Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV Against Influenza a Viruses in Children
Vaccines
Drug Discovery
Infectious Diseases
Immunology
Pharmacology
Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink
Archives of Pediatrics & Adolescent Medicine
Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Cross-Reactive Antibody to Swine Influenza A(H3N2) Subtype Virus in Children and Adults Before and After Immunisation With 2010/11 Trivalent Inactivated Influenza Vaccine in Canada, August to November 2010
Eurosurveillance
Environmental
Virology
Public Health
Epidemiology
Medicine
Occupational Health
Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost
Contemporary Clinical Trials
Medicine
Pharmacology
Genetic and Antigenic Characterization of Influenza A(H3N2) in Cameroon During the 2014-2016 Influenza Seasons
PLoS ONE
Multidisciplinary
